NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.310
-0.050 (-3.68%)
Apr 17, 2026, 5:29 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 145.92 million as of April 17, 2026. Its market cap has decreased by -30.68% in one year.
Market Cap
145.92M
Enterprise Value
119.89M
Revenue
9.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.31
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 145.92M, an increase of 341.85%. That is a compound annual growth rate of 18.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 145.92M | 79.21% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 232.06M |
| Xintela AB | 229.96M |
| Alligator Bioscience AB | 226.12M |
| Diamyd Medical AB | 209.23M |
| Isofol Medical AB | 201.83M |
| Active Biotech AB | 188.48M |
| Xbrane Biopharma AB | 170.61M |
| AlzeCure Pharma AB | 170.07M |